ArticlePloS one2026
Developing a clinical case definition for Chikungunya fever in the Democratic Republic of the Congo.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionChikungunya fever presents a diagnostic challenge in Sub-Saharan Africa due to the absence of a region-specific case definition, especially in settings with high disease burden and diverse aetiologies of acute febrile illnesses. Our study aimed to develop an evidence-based clinical case definition for acute Chikungunya virus (CHIKV) infection suitable for use at resource-limited primary health care level.
methodsWe conducted a cross-sectional study in Kinshasa, Democratic Republic of the Congo, between June and November 2019 during an ongoing CHIKV outbreak. Patients aged ≥3 years with symptoms suggestive of acute CHIKV infection were enrolled. Clinical examination data and blood samples were collected for CHIKV diagnosis via PCR and ELISA. Malaria rapid diagnostic tests were also performed. We used Classification and Regression Tree (CART) analysis with 10-fold cross-validation and predictive logistic regression models with lasso penalty, with performance assessed via the Area under the Receiver Operating Characteristics Curve (AUC).
resultsOf 132 analysed patients, 40.2% had acute CHIKV infection. CART analysis identified knee and shoulder pain as potential predictors, however classifying only 67.4% of patients correctly while missing 71.7% of cases (cross-validated AUC 53%; 95%CI 43%-63%). Logistic regression achieved 61.1% accuracy, with a corresponding cross-validated AUC of 62% (95%CI 52%-72%). Exploratory analysis excluding malaria co-infections yielded similar CART performance, while logistic regression failed to identify any reliable predictors.
conclusionsWhile our study provides valuable insights into the clinical presentation of CHIKV in Sub-Saharan Africa, it highlights the challenges of developing a simple symptom-based diagnostic algorithm suitable for resource-limited primary health care settings. Certain joint pain patterns showed predictive value, however no model achieved sufficient accuracy for clinical use. Improved access to serological testing and integration of epidemiological context are essential for CHIKV diagnosis in such contexts. Further research is needed to refine clinical criteria and support outbreak response in resource-limited regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.